Endologix To Participate In Two Investor Conferences In March

IRVINE, Calif., March 6, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chairman and Chief Executive Officer, and Shelley Thunen, Chief Financial Officer, are scheduled to participate at two investor conferences in March. The first conference is the 26th Annual ROTH Conference in Dana Point, CA.
Event: 26th Annual ROTH Conference
Date: Monday, March 10, 2014
Time: 3:30 p.m. PT / 6:30 p.m. ET
Endologix Participants: John McDermott and Shelley Thunen

The second conference is the BTIG Inaugural Snowbird Medical Technology, Diagnostics, and Healthcare IT Conference in Snowbird, UT. This conference will allow institutional investors to meet with the Company but does not include a formal presentation.
Event: BTIG Inaugural Snowbird Medical Technology, Diagnostics, and Healthcare IT Conference
Date: March 18-19, 2014
Endologix Participant: Shelley Thunen

An audio webcast of the Company's presentation at the 26th Annual ROTH Conference will be available by visiting the investor relations section of Endologix's website at www.endologix.com. A replay of the presentation will be available for 30 days.

About Endologix, Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. Endologix focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's website at www.endologix.com.
CONTACT: COMPANY CONTACT:         Endologix, Inc.         John McDermott, CEO         Shelley Thunen, CFO         (949) 595-7200         www.endologix.com                  INVESTOR CONTACTS:         The Ruth Group         Nick Laudico (646) 536-7030         Zack Kubow (646) 536-7020

If you liked this article you might like

Endologix Poised for a Potentially Volatile Breakout

5 Stocks Trending Close to Major Breakouts

5 Stocks Set for Explosive Breakouts

These 5 Stocks Under $10 Could Make You a Lot of Money

Week in Review: Trump Rally Fizzles but Stocks End 2016 With Big Gains